JonesResearch upgraded Korro Bio (KRRO) to Buy from Hold with a $23 price target
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KRRO:
- Korro Bio reports Q1 EPS ($1.69), consensus ($1.98)
- Korro Bio files to sell 7.65M shares of common stock for holders
- Korro Bio price target raised to $22 from $21 at Cantor Fitzgerald
- Korro Bio upgraded to Outperform from Market Perform at Raymond James
- Korro Bio Announces Oversubscribed $85M PIPE Financing